ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States
Description
Brief Summary
Multi-center, prospective non-interventional study to collect data on the early use of
ADSTILADRIN in the US. Data will be collected from participants, caregivers and prescribing
physicians in a real-world setting.
Phase
N/AInclusion and Exclusion Criteria
- Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
- Signed and dated ICF.
- Age 18 years or older at day ICF is signed.
- Currently enrolled in a clinical trial.
- Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
- Participant is pregnant or breastfeeding.
Sites
Please contact the trial administrator to learn more about where you can participate in this trial. Please use the contact form on the right side.
Powered by
SC CTSI